Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genome-Wide Association Mapping and Integrated Transcriptomic-Genomic Analysis Reveal Candidate Genes for Grain Transparency in Rice.

International journal of molecular sciences·2026
Same author

Robust and interpretable tabular data classification via multi-channel image conversion and channel-wise gating.

Neural networks : the official journal of the International Neural Network Society·2026
Same author

PSMC5 Orchestrates an Immunosuppressive Niche and Metastasis in Colorectal Cancer via SMURF1-Mediated K11-Linked Ubiquitination of METTL14.

International journal of biological sciences·2026
Same author

Analytical Assessment of sgRNA Impurities and Their Impact on Functional Performance.

Analytical chemistry·2026
Same author

In-process analytics for IVT mRNA manufacturing: from process understanding to advanced process control.

Frontiers in bioengineering and biotechnology·2026
Same author

Unveiling the prognostic and therapeutic landscape of the zinc transporter protein SLC39A family in colorectal cancer through multi-omics and machine learning approaches.

Clinical and experimental medicine·2026

Related Experiment Video

Updated: Aug 31, 2025

Using Sniper-Cas9 to Minimize Off-target Effects of CRISPR-Cas9 Without the Loss of On-target Activity Via Directed Evolution
11:37

Using Sniper-Cas9 to Minimize Off-target Effects of CRISPR-Cas9 Without the Loss of On-target Activity Via Directed Evolution

Published on: February 26, 2019

9.8K

Comprehensive UHPLC- and CE-based methods for engineered Cas9 characterization.

Julien Camperi1, Gary Console2, Laura Zheng2

  • 1Cell Therapy Engineering and Development, Genentech, 1 DNA Way, South San Francisco, CA, 94080, USA.

Talanta
|August 21, 2022
PubMed
Summary

Engineered CRISPR-Cas9 variants, like high-fidelity SpyFi Cas9, offer improved gene editing. New UHPLC and CE methods fully characterize these variants, ensuring purity, modifications, and function for therapeutic applications.

Keywords:
CRISPR-Cas9Capillary electrophoresisEngineered Cas9Liquid chromatographyPeptide mapping

More Related Videos

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
10:44

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

1.5K
CIRCLE-Seq for Interrogation of Off-Target Gene Editing
08:23

CIRCLE-Seq for Interrogation of Off-Target Gene Editing

Published on: November 1, 2024

835

Related Experiment Videos

Last Updated: Aug 31, 2025

Using Sniper-Cas9 to Minimize Off-target Effects of CRISPR-Cas9 Without the Loss of On-target Activity Via Directed Evolution
11:37

Using Sniper-Cas9 to Minimize Off-target Effects of CRISPR-Cas9 Without the Loss of On-target Activity Via Directed Evolution

Published on: February 26, 2019

9.8K
In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
10:44

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

1.5K
CIRCLE-Seq for Interrogation of Off-Target Gene Editing
08:23

CIRCLE-Seq for Interrogation of Off-Target Gene Editing

Published on: November 1, 2024

835

Area of Science:

  • Biochemistry and Molecular Biology
  • Analytical Chemistry
  • Gene Editing Technologies

Background:

  • CRISPR-Cas9 systems are crucial gene-editing tools with therapeutic potential.
  • Minimizing off-target effects of CRISPR-Cas9 is essential for safe therapeutic applications.
  • Engineered Cas9 variants, such as high-fidelity SpyFi Cas9, aim to enhance specificity and reduce unwanted mutations.

Purpose of the Study:

  • To develop and validate ultra-high-performance liquid chromatography (UHPLC) and capillary electrophoresis (CE) methods for comprehensive characterization of engineered Cas9 variants.
  • To assess purity, size variants, isoelectric points (pI), post-translational modifications (PTMs), and functional activities of different Cas9 variants.
  • To establish methods for differentiating engineered variants like SpyFi Cas9 from wild-type Streptococcus pyogenes Cas9 (SpCas9).

Main Methods:

  • Purity and size variants determined by CE-sodium dodecyl sulfate (SDS).
  • Functional activity assessed via in vitro DNA cleavage assays using ribonucleoprotein (RNP) complexes.
  • Isoelectric points (pI) measured by imaged capillary isoelectric focusing (icIEF); intact mass analysis by reversed-phase (RP)-UHPLC coupled with high-resolution mass spectrometry (HRMS).
  • Peptide mapping using LC-UV-MS/MS with endoproteinase Lys-C for sequence confirmation.

Main Results:

  • Developed robust UHPLC and CE methods for full characterization of engineered Cas9 variants.
  • Successfully differentiated SpyFi Cas9 from WT SpCas9 using peptide mapping and mass spectrometry.
  • Demonstrated the utility of these analytical techniques for assessing critical quality attributes of gene-editing proteins.

Conclusions:

  • The developed UHPLC and CE methods provide a comprehensive analytical toolkit for characterizing engineered Cas9 variants.
  • These methods are crucial for ensuring the quality, consistency, and safety of Cas9-based therapeutics.
  • Low-resolution mass spectrometry may serve as a cost-effective method for identifying specific variants like SpyFi Cas9 in GMP environments.